NDAORALTABLETPriority Review
Approved
Mar 1964
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Protopam Chloride (pralidoxime chloride) is a small-molecule antidote used to reverse poisoning from organophosphate compounds, including certain pesticides and nerve agents. It works as a cholinesterase reactivator, restoring enzyme function impaired by organophosphate exposure. The drug is indicated for acute organophosphate poisoning management.
LOE Approaching
Legacy product in final patent life with minimal team expansion; focus shifts to managed decline and supply continuity rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Protopam roles focus on product stewardship, regulatory compliance, and supply continuity rather than commercial growth. Career opportunities are limited in scale but valuable for specialists in toxicology, emergency medicine, and highly regulated niche markets.
Regulatory Affairs SpecialistSupply Chain / Manufacturing Operations
Worked on PROTOPAM CHLORIDE at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.